FDA inspection
Genvion Corporation: FDA inspection ending Jul 28, 2023
FDA inspection 1216476 · Voluntary Action Indicated (VAI) · Winnipeg
Key facts
| Inspection ID | 1216476 |
|---|---|
| Firm | Genvion Corporation |
| FEI number | 3010164251 |
| Address | 500 Camiel Sys St |
| City | Winnipeg |
| Country | Canada |
| Fiscal year | 2023 |
| Inspection end date | Jul 28, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data